Amyris (NASDAQ:AMRS) reported Q2 EPS of ($0.34), $0.05 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $78.68 million.
Amyris (NASDAQ:AMRS) reported Q2 EPS of ($0.34), $0.05 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $65.2 million versus the consensus estimate of $78.68 million.